---
title: "Barclays Sticks to Its Buy Rating for Alpha Tau Medical Ltd (DRTS)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292598031.md"
description: "Barclays analyst Lukas Shumway maintained a Buy rating on Alpha Tau Medical Ltd (DRTS) with a $17.00 price target, citing his coverage of the Healthcare sector. While Shumway holds a 2-star rating, the broader market consensus for DRTS is Strong Buy with an average price target of $13.50. Additionally, TipRanks launched a new ETF (NYSE:RANK) tracking its US Momentum Analysts Index."
datetime: "2026-07-14T09:05:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292598031.md)
  - [en](https://longbridge.com/en/news/292598031.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292598031.md)
---

# Barclays Sticks to Its Buy Rating for Alpha Tau Medical Ltd (DRTS)

In a report released today, Lukas Shumway from Barclays maintained a Buy rating on Alpha Tau Medical Ltd, with a price target of $17.00.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

According to TipRanks, Shumway is a 2-star analyst with an average return of 5.8% and a 57.14% success rate. Shumway covers the Healthcare sector, focusing on stocks such as Alpha Tau Medical Ltd, Immunome, and Sutro Biopharma.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Alpha Tau Medical Ltd with a $13.50 average price target.

### Related Stocks

- [DRTS.US](https://longbridge.com/en/quote/DRTS.US.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)
- [IMNM.US](https://longbridge.com/en/quote/IMNM.US.md)
- [STRO.US](https://longbridge.com/en/quote/STRO.US.md)
- [DRTSW.US](https://longbridge.com/en/quote/DRTSW.US.md)

## Related News & Research

- [Roth MKM Reaffirms Their Buy Rating on Trulite (TRUL)](https://longbridge.com/en/news/293045966.md)
- [Alpha Tau Posts Strong Alpha DaRT–Keytruda Data in Head and Neck Cancer Study](https://longbridge.com/en/news/293346278.md)
- [United States Brent Oil Fund LP ETF announces June NAV of $40.41](https://longbridge.com/en/news/294302677.md)
- [1 brilliant ETF I'm loading up on if inflation continues climbing](https://longbridge.com/en/news/294341440.md)
- [How investors can navigate the healthcare sector](https://longbridge.com/en/news/293960711.md)